{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:13:25Z","timestamp":1788416005118,"version":"build-2803163510"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Programmed endometrial preparation is widely used for frozen embryo transfer (FET) because it allows flexible scheduling. Recent randomized evidence has shown that programmed regimens increase the risk of hypertensive disorders of pregnancy, particularly pre-eclampsia, compared with natural ovulation regimens. However, it remains unclear whether this risk is distributed uniformly across patients or concentrated in women with specific baseline characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to evaluate the heterogeneous treatment effects of programmed regimens versus natural ovulation regimens on pre-eclampsia after FET and to identify baseline phenotypes associated with increased vulnerability across multiple adverse obstetric outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed an exploratory secondary analysis of a multicentre, open-label randomized clinical trial comparing programmed and natural ovulation regimens for endometrial preparation before FET. The analysis was restricted to women with regular menstrual cycles who achieved clinical pregnancy after FET. The primary outcome was pre-eclampsia. Secondary outcomes included late-onset pre-eclampsia, placenta accreta spectrum, postpartum haemorrhage and caesarean delivery. Inverse probability of treatment weighting was used to improve covariate balance. Individualized treatment effects were estimated using causal forests. Restricted cubic spline models were used as a sensitivity analysis to examine statistical interactions between treatment regimen and key baseline variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 2,541 women included in the analytical cohort, 1,261 were assigned to natural ovulation and 1,280 to programmed treatment. Pre-eclampsia occurred in 38 women (3.01%) in the natural ovulation group and 60 women (4.69%) in the programmed group, corresponding to an unadjusted absolute risk difference of 1.67 percentage points. The causal forest estimated positive CATEs for all participants (100.0%), with a median estimated absolute risk increase of 1.51 percentage points (IQR, 1.37\u20131.83). BMI, AMH, and the retrieval-to-randomization interval were the leading contributors to model-estimated treatment-effect heterogeneity. Conventional regression analysis supported a statistically significant treatment interaction for BMI (\n                      <jats:italic>P<\/jats:italic>\n                      for interaction\u2009=\u20090.039), whereas interactions involving AMH and the retrieval-to-randomization interval were not statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Programmed FET regimens were associated with a higher absolute risk of pre-eclampsia in the pregnancy-conditioned analytical cohort, although the estimated magnitude of this increase varied across participants. BMI showed the strongest support as a treatment-effect modifier in conventional regression analysis, whereas AMH and the retrieval-to-randomization interval should be interpreted as exploratory candidate modifiers identified by causal forest analysis. These findings require prospective validation before they can be used to guide individualized regimen selection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1871107","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:22:22Z","timestamp":1788412942000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Identifying systemic vulnerability phenotypes associated with programmed regimens in frozen embryo transfer: a secondary analysis of a multicentre randomized clinical trial"],"prefix":"10.3389","volume":"13","author":[{"given":"Junfeng","family":"Chen","sequence":"first","affiliation":[{"name":"Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Li","sequence":"additional","affiliation":[{"name":"Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengfei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailian","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Qu","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Li","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.fertnstert.2026.03.021","article-title":"Frozen versus fresh embryo transfer in low responders: a systematic review","volume":"126","author":"Sun","year":"2026","journal-title":"Fertil Steril"},{"key":"B2","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.fertnstert.2026.02.021","article-title":"Modified natural vs. natural cycle for endometrial preparation in frozen embryo transfer: a meta-analysis","volume":"125","author":"Venetis","year":"2026","journal-title":"Fertil Steril"},{"key":"B3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/humupd\/dmaf026","article-title":"Female fertility preservation: 25 years of progress, expanding indications and future prospects","volume":"32","author":"Sonmezer","year":"2026","journal-title":"Hum Reprod Update"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1668960","DOI":"10.3389\/fcell.2025.1668960","article-title":"Regenerative therapies for refractory thin endometrium in in vitro fertilization","volume":"13","author":"Chen","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"B5","first-page":"498","article-title":"ESHRE guideline: ovarian stimulation for IVF\/ICSI: an update in 2025\u2020","volume":"41","author":"Ata","year":"2026","journal-title":"Hum Reprod"},{"key":"B6","doi-asserted-by":"publisher","first-page":"Cd003414","DOI":"10.1002\/14651858.CD003414.pub4","article-title":"Cycle regimens for endometrial preparation prior to frozen embryo transfer","volume":"6","author":"Ghobara","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e087045","DOI":"10.1136\/bmj-2025-087045","article-title":"Natural ovulation versus programmed regimens before frozen embryo transfer in ovulatory women: multicentre, randomised clinical trial","volume":"392","author":"Wei","year":"2026","journal-title":"BMJ"},{"key":"B8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.fertnstert.2019.12.007","article-title":"Frozen-thawed embryo transfer: the potential importance of the corpus luteum in preventing obstetrical complications","volume":"113","author":"Singh","year":"2020","journal-title":"Fertil Steril"},{"key":"B9","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1161\/HYPERTENSIONAHA.118.12046","article-title":"Absent or excessive corpus luteum number is associated with altered maternal vascular health in early pregnancy.","volume":"73","author":"von Versen-H\u00f6ynck","year":"2019","journal-title":"Hypertension"},{"key":"B10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s40001-025-02372-2","article-title":"Differential optimal follicle sizes for ovulatory dysfunction and unexplained infertility in LE-IUI cycles: a retrospective analysis","volume":"30","author":"Liang","year":"2025","journal-title":"Eur J Med Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/humupd\/dmag002","article-title":"Revisiting natural cycle frozen embryo transfer: a systematic review and meta-analysis","volume":"32","author":"Erden","year":"2026","journal-title":"Hum Reprod Update"},{"key":"B12","doi-asserted-by":"publisher","first-page":"10732748261447089","DOI":"10.1177\/10732748261447089","article-title":"Comparative analysis of machine learning algorithms for prognostic prediction in pulmonary large cell carcinoma","volume":"33","author":"Yang","year":"2026","journal-title":"Cancer Control"},{"key":"B13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.kint.2026.02.041","article-title":"Advances in survival analyses: machine learning methods and model comparison","volume":"110","author":"Gately","year":"2026","journal-title":"Kidney Int"},{"key":"B14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-bioeng-110824-124907","article-title":"Physics-informed machine learning in biomedical science and engineering","volume":"28","author":"Ahmadi","year":"2026","journal-title":"Annu Rev Biomed Eng"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1770869","DOI":"10.3389\/fcvm.2026.1770869","article-title":"A systematic review of multimodal machine learning models for heart failure classification and prognosis prediction","volume":"13","author":"Hoang","year":"2026","journal-title":"Front Cardiovasc Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"11091","DOI":"10.3390\/ijms262211091","article-title":"Late vs. early preeclampsia","volume":"26","author":"Kariori","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.3390\/jcm14093121","article-title":"Long-term cardiovascular risk and maternal history of pre-eclampsia","volume":"14","author":"Palmiero","year":"2025","journal-title":"J Clin Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1093\/humrep\/deac073","article-title":"Obstetric and perinatal outcomes following programmed compared to natural frozen-thawed embryo transfer cycles: a systematic review and meta-analysis","volume":"37","author":"Busnelli","year":"2022","journal-title":"Hum Reprod"},{"key":"B19","doi-asserted-by":"publisher","first-page":"111338","DOI":"10.1016\/j.jclinepi.2024.111338","article-title":"Use and reporting of inverse-probability-of-treatment weighting for multicategory treatments in medical research: a systematic review","volume":"170","author":"Bettega","year":"2024","journal-title":"J Clin Epidemiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"ezag122","DOI":"10.1093\/ejcts\/ezag122","article-title":"Use of inverse probability weighting in cardiovascular surgical outcomes research: principles, limitations, and recommendations.","volume":"68","author":"Liu","year":"2026","journal-title":"Eur J Cardiothorac Surg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41574-023-00921-5","article-title":"Luteal phase support in assisted reproductive technology","volume":"20","author":"Garg","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.fertnstert.2008.07.1745","article-title":"The human corpus luteum: life cycle and function in natural cycles","volume":"92","author":"Devoto","year":"2009","journal-title":"Fertil Steril"},{"key":"B23","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.rbmo.2014.01.012","article-title":"Improving the luteal phase after ovarian stimulation: reviewing new options","volume":"28","author":"Yding Andersen","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"B24","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.fertnstert.2022.07.025","article-title":"Association between programmed frozen embryo transfer and hypertensive disorders of pregnancy","volume":"118","author":"Bortoletto","year":"2022","journal-title":"Fertil Steril"},{"key":"B25","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/humupd\/dmab003","article-title":"Secretory products of the corpus luteum and preeclampsia","volume":"27","author":"Pereira","year":"2021","journal-title":"Hum Reprod Update"},{"key":"B26","doi-asserted-by":"publisher","first-page":"104941","DOI":"10.1016\/j.rbmo.2025.104941","article-title":"From body mass index to body composition in female infertility","volume":"51","author":"Dar\u0131c\u0131","year":"2025","journal-title":"Reprod Biomed Online"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s00404-025-08137-w","article-title":"Endometriosis as a risk factor: impact on IVF outcomes and reproductive parameters: a systematic review and meta-analysis","volume":"312","author":"Liao","year":"2025","journal-title":"Arch Gynecol Obstet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10238-025-01902-w","article-title":"Beyond single biomarkers: multi-omics strategies to predict immunotherapy outcomes in blood cancers","volume":"25","author":"Pirouzbakht","year":"2025","journal-title":"Clin Exp Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"102810","DOI":"10.1016\/j.ssresearch.2022.102810","article-title":"Heterogeneous treatment effects analysis for social scientists: a review","volume":"109","author":"Hu","year":"2023","journal-title":"Soc Sci Res"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1871107\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:22:23Z","timestamp":1788412943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1871107\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":29,"alternative-id":["10.3389\/fmed.2026.1871107"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1871107","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1871107"}}